Structure

Physi-Chem Properties

Molecular Weight:  572.24
Volume:  592.522
LogP:  3.945
LogD:  2.944
LogS:  -4.376
# Rotatable Bonds:  8
TPSA:  126.43
# H-Bond Aceptor:  8
# H-Bond Donor:  3
# Rings:  5
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.259
Synthetic Accessibility Score:  4.934
Fsp3:  0.353
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.105
MDCK Permeability:  1.6168496586033143e-05
Pgp-inhibitor:  0.926
Pgp-substrate:  0.317
Human Intestinal Absorption (HIA):  0.14
20% Bioavailability (F20%):  0.897
30% Bioavailability (F30%):  0.978

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.8
Plasma Protein Binding (PPB):  99.80879974365234%
Volume Distribution (VD):  1.065
Pgp-substrate:  3.544963836669922%

ADMET: Metabolism

CYP1A2-inhibitor:  0.484
CYP1A2-substrate:  0.095
CYP2C19-inhibitor:  0.645
CYP2C19-substrate:  0.059
CYP2C9-inhibitor:  0.627
CYP2C9-substrate:  0.867
CYP2D6-inhibitor:  0.962
CYP2D6-substrate:  0.16
CYP3A4-inhibitor:  0.802
CYP3A4-substrate:  0.201

ADMET: Excretion

Clearance (CL):  10.398
Half-life (T1/2):  0.602

ADMET: Toxicity

hERG Blockers:  0.477
Human Hepatotoxicity (H-HT):  0.318
Drug-inuced Liver Injury (DILI):  0.917
AMES Toxicity:  0.004
Rat Oral Acute Toxicity:  0.304
Maximum Recommended Daily Dose:  0.885
Skin Sensitization:  0.313
Carcinogencity:  0.134
Eye Corrosion:  0.003
Eye Irritation:  0.04
Respiratory Toxicity:  0.422

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC472556

Natural Product ID:  NPC472556
Common Name*:   INDRXXKQJAKWRM-OMAAXZSASA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  INDRXXKQJAKWRM-OMAAXZSASA-N
Standard InCHI:  InChI=1S/C34H36O8/c1-21-25(35)15-16-26-32(2,18-17-22-19-27(36)40-20-22)34(4,39)29(42-31(38)24-13-9-6-10-14-24)28(33(21,26)3)41-30(37)23-11-7-5-8-12-23/h5-14,17-19,25-26,28-29,35,39H,1,15-16,20H2,2-4H3/b18-17+/t25-,26+,28-,29-,32+,33-,34-/m0/s1
SMILES:  CC1(C2CCC(C(=C)C2(C(C(C1(C)O)OC(=O)C3=CC=CC=C3)OC(=O)C4=CC=CC=C4)C)O)C=CC5=CC(=O)OC5
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3577092
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001538] Diterpene lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. whole plant n.a. PMID[16755060]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. aerial part n.a. PMID[17666848]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. aerial part n.a. PMID[18239311]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[19785430]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[19962306]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[20078074]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota whole plants Nanning District, Guangxi Province, China 2012-Sep PMID[25647077]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota aerial parts Seoul, Korea n.a. PMID[26331882]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO16039 Scutellaria barbata Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT164 Organism Human herpesvirus 4 Human herpesvirus 4 Inhibition < 50.0 % PMID[517614]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC472556 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.971 High Similarity NPC174982
0.971 High Similarity NPC472571
0.971 High Similarity NPC96903
0.971 High Similarity NPC473088
0.971 High Similarity NPC472575
0.971 High Similarity NPC470159
0.971 High Similarity NPC476973
0.971 High Similarity NPC171525
0.971 High Similarity NPC158663
0.971 High Similarity NPC472568
0.971 High Similarity NPC470157
0.971 High Similarity NPC177940
0.971 High Similarity NPC471104
0.971 High Similarity NPC184817
0.971 High Similarity NPC200471
0.971 High Similarity NPC469349
0.971 High Similarity NPC472572
0.971 High Similarity NPC70403
0.971 High Similarity NPC29704
0.9638 High Similarity NPC241951
0.9638 High Similarity NPC125106
0.9638 High Similarity NPC70716
0.9638 High Similarity NPC11685
0.9638 High Similarity NPC476974
0.9638 High Similarity NPC188865
0.9638 High Similarity NPC470152
0.9638 High Similarity NPC472573
0.9638 High Similarity NPC25768
0.9638 High Similarity NPC475759
0.9638 High Similarity NPC57628
0.9638 High Similarity NPC472570
0.9638 High Similarity NPC472569
0.9638 High Similarity NPC475122
0.9638 High Similarity NPC95265
0.9638 High Similarity NPC163719
0.9638 High Similarity NPC95810
0.9565 High Similarity NPC91703
0.9565 High Similarity NPC163087
0.9562 High Similarity NPC224491
0.9507 High Similarity NPC470153
0.9504 High Similarity NPC476975
0.9504 High Similarity NPC266265
0.9504 High Similarity NPC301556
0.9504 High Similarity NPC270590
0.9504 High Similarity NPC92293
0.9504 High Similarity NPC471101
0.9489 High Similarity NPC472547
0.9437 High Similarity NPC473214
0.9437 High Similarity NPC470245
0.9433 High Similarity NPC281717
0.942 High Similarity NPC87448
0.942 High Similarity NPC16912
0.942 High Similarity NPC291599
0.942 High Similarity NPC97947
0.942 High Similarity NPC27377
0.942 High Similarity NPC41481
0.942 High Similarity NPC472576
0.942 High Similarity NPC118080
0.9366 High Similarity NPC473215
0.9362 High Similarity NPC474935
0.9362 High Similarity NPC473602
0.9348 High Similarity NPC473060
0.9348 High Similarity NPC100913
0.9348 High Similarity NPC476094
0.9348 High Similarity NPC275592
0.9348 High Similarity NPC473081
0.9348 High Similarity NPC211137
0.9348 High Similarity NPC90614
0.9348 High Similarity NPC4341
0.9348 High Similarity NPC184747
0.9348 High Similarity NPC473112
0.9348 High Similarity NPC43241
0.9348 High Similarity NPC473758
0.9348 High Similarity NPC147880
0.9348 High Similarity NPC171207
0.9348 High Similarity NPC473085
0.9348 High Similarity NPC97667
0.9348 High Similarity NPC473109
0.9348 High Similarity NPC200592
0.9348 High Similarity NPC48017
0.9348 High Similarity NPC473613
0.9343 High Similarity NPC39549
0.9306 High Similarity NPC477905
0.9275 High Similarity NPC214550
0.9275 High Similarity NPC475652
0.9275 High Similarity NPC210591
0.927 High Similarity NPC472545
0.927 High Similarity NPC472551
0.9214 High Similarity NPC472546
0.9214 High Similarity NPC34012
0.9203 High Similarity NPC183122
0.9203 High Similarity NPC283375
0.9172 High Similarity NPC472548
0.9167 High Similarity NPC7095
0.9149 High Similarity NPC177340
0.9149 High Similarity NPC191082
0.9149 High Similarity NPC473673
0.9149 High Similarity NPC270498
0.9149 High Similarity NPC477894
0.9149 High Similarity NPC475429
0.9149 High Similarity NPC147217
0.9149 High Similarity NPC139067
0.9149 High Similarity NPC246480
0.9116 High Similarity NPC106895
0.911 High Similarity NPC158333
0.911 High Similarity NPC472022
0.911 High Similarity NPC265395
0.911 High Similarity NPC242262
0.911 High Similarity NPC1173
0.911 High Similarity NPC256142
0.911 High Similarity NPC473414
0.911 High Similarity NPC257213
0.911 High Similarity NPC472030
0.911 High Similarity NPC249471
0.911 High Similarity NPC472005
0.911 High Similarity NPC237549
0.911 High Similarity NPC304876
0.9097 High Similarity NPC250046
0.9097 High Similarity NPC60509
0.9097 High Similarity NPC81698
0.9085 High Similarity NPC51314
0.9085 High Similarity NPC38696
0.9085 High Similarity NPC67777
0.9085 High Similarity NPC470231
0.9085 High Similarity NPC34943
0.9078 High Similarity NPC192658
0.9058 High Similarity NPC472577
0.9058 High Similarity NPC66761
0.9058 High Similarity NPC195647
0.9058 High Similarity NPC291638
0.9058 High Similarity NPC17877
0.9048 High Similarity NPC228204
0.9048 High Similarity NPC26033
0.9048 High Similarity NPC472549
0.9048 High Similarity NPC282239
0.9048 High Similarity NPC112523
0.9048 High Similarity NPC114410
0.9034 High Similarity NPC31829
0.9034 High Similarity NPC112216
0.9034 High Similarity NPC198455
0.9034 High Similarity NPC161239
0.9034 High Similarity NPC469448
0.9034 High Similarity NPC165260
0.9028 High Similarity NPC473760
0.9007 High Similarity NPC266374
0.8993 High Similarity NPC472372
0.8993 High Similarity NPC472374
0.8986 High Similarity NPC48929
0.8986 High Similarity NPC474608
0.8986 High Similarity NPC217091
0.898 High Similarity NPC77719
0.8958 High Similarity NPC20255
0.8958 High Similarity NPC48599
0.8958 High Similarity NPC209592
0.8958 High Similarity NPC240115
0.8936 High Similarity NPC87934
0.8936 High Similarity NPC162613
0.8926 High Similarity NPC469771
0.8926 High Similarity NPC472393
0.8921 High Similarity NPC477893
0.8921 High Similarity NPC477896
0.8919 High Similarity NPC132599
0.8919 High Similarity NPC34066
0.8919 High Similarity NPC473670
0.8919 High Similarity NPC473632
0.8919 High Similarity NPC473611
0.8919 High Similarity NPC469730
0.8919 High Similarity NPC21410
0.8889 High Similarity NPC125882
0.8889 High Similarity NPC92867
0.8889 High Similarity NPC127857
0.8889 High Similarity NPC311825
0.8874 High Similarity NPC476077
0.8867 High Similarity NPC471102
0.8865 High Similarity NPC9905
0.8851 High Similarity NPC472658
0.8851 High Similarity NPC472657
0.8844 High Similarity NPC471103
0.8844 High Similarity NPC51602
0.8832 High Similarity NPC147561
0.8828 High Similarity NPC312393
0.8811 High Similarity NPC182869
0.8803 High Similarity NPC183270
0.8803 High Similarity NPC477904
0.8792 High Similarity NPC469422
0.8776 High Similarity NPC254558
0.8767 High Similarity NPC217918
0.875 High Similarity NPC477468
0.875 High Similarity NPC473220
0.875 High Similarity NPC470753
0.875 High Similarity NPC95449
0.8742 High Similarity NPC469399
0.8716 High Similarity NPC101043
0.8716 High Similarity NPC197037
0.8716 High Similarity NPC306799
0.8707 High Similarity NPC76103
0.8699 High Similarity NPC478263
0.8684 High Similarity NPC477623
0.8676 High Similarity NPC470765
0.8676 High Similarity NPC275576

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC472556 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8133 Intermediate Similarity NPD7236 Approved
0.8042 Intermediate Similarity NPD5952 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD7239 Suspended
0.7927 Intermediate Similarity NPD8470 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD7799 Discontinued
0.7793 Intermediate Similarity NPD7008 Discontinued
0.7778 Intermediate Similarity NPD8360 Approved
0.7778 Intermediate Similarity NPD8361 Approved
0.7765 Intermediate Similarity NPD8434 Phase 2
0.7679 Intermediate Similarity NPD8368 Discontinued
0.7674 Intermediate Similarity NPD8435 Approved
0.7669 Intermediate Similarity NPD8127 Discontinued
0.7661 Intermediate Similarity NPD8424 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD4628 Phase 3
0.7647 Intermediate Similarity NPD8166 Discontinued
0.7647 Intermediate Similarity NPD8407 Phase 2
0.7614 Intermediate Similarity NPD8485 Approved
0.7571 Intermediate Similarity NPD7741 Discontinued
0.7536 Intermediate Similarity NPD2629 Approved
0.7531 Intermediate Similarity NPD7057 Phase 3
0.7531 Intermediate Similarity NPD7058 Phase 2
0.7516 Intermediate Similarity NPD6273 Approved
0.75 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD8486 Clinical (unspecified phase)
0.7466 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7457 Intermediate Similarity NPD8150 Discontinued
0.745 Intermediate Similarity NPD7961 Discontinued
0.741 Intermediate Similarity NPD5951 Approved
0.7396 Intermediate Similarity NPD5844 Phase 1
0.7386 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD8313 Approved
0.7384 Intermediate Similarity NPD8312 Approved
0.7383 Intermediate Similarity NPD3764 Approved
0.7375 Intermediate Similarity NPD7458 Discontinued
0.7372 Intermediate Similarity NPD6190 Approved
0.7357 Intermediate Similarity NPD4198 Discontinued
0.7346 Intermediate Similarity NPD37 Approved
0.7317 Intermediate Similarity NPD4966 Approved
0.7317 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD4965 Approved
0.7317 Intermediate Similarity NPD4967 Phase 2
0.7308 Intermediate Similarity NPD7003 Approved
0.7285 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7261 Intermediate Similarity NPD7274 Clinical (unspecified phase)
0.7235 Intermediate Similarity NPD7228 Approved
0.7233 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD6234 Discontinued
0.7226 Intermediate Similarity NPD7702 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD5126 Approved
0.7222 Intermediate Similarity NPD7163 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD5125 Phase 3
0.7222 Intermediate Similarity NPD4380 Phase 2
0.7212 Intermediate Similarity NPD7768 Phase 2
0.7195 Intermediate Similarity NPD8455 Phase 2
0.7195 Intermediate Similarity NPD7819 Suspended
0.7176 Intermediate Similarity NPD7473 Discontinued
0.7175 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD7075 Discontinued
0.7168 Intermediate Similarity NPD7685 Pre-registration
0.716 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7122 Intermediate Similarity NPD2181 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD7266 Discontinued
0.711 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD3412 Clinical (unspecified phase)
0.7101 Intermediate Similarity NPD6232 Discontinued
0.7101 Intermediate Similarity NPD6831 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD6591 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD5404 Approved
0.7051 Intermediate Similarity NPD5406 Approved
0.7051 Intermediate Similarity NPD5408 Approved
0.7051 Intermediate Similarity NPD5405 Approved
0.7048 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD5402 Approved
0.7043 Intermediate Similarity NPD8319 Approved
0.7043 Intermediate Similarity NPD8320 Phase 1
0.7042 Intermediate Similarity NPD690 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD5403 Approved
0.703 Intermediate Similarity NPD6801 Discontinued
0.7025 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7019 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7014 Intermediate Similarity NPD7610 Discontinued
0.7012 Intermediate Similarity NPD6599 Discontinued
0.6995 Remote Similarity NPD7699 Phase 2
0.6995 Remote Similarity NPD7700 Phase 2
0.6993 Remote Similarity NPD7714 Approved
0.6993 Remote Similarity NPD6663 Approved
0.6993 Remote Similarity NPD7715 Approved
0.6989 Remote Similarity NPD7497 Discontinued
0.6988 Remote Similarity NPD5761 Phase 2
0.6988 Remote Similarity NPD5760 Phase 2
0.6981 Remote Similarity NPD3750 Approved
0.6978 Remote Similarity NPD2182 Approved
0.6971 Remote Similarity NPD7240 Approved
0.6971 Remote Similarity NPD6559 Discontinued
0.697 Remote Similarity NPD7411 Suspended
0.6964 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6957 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6954 Remote Similarity NPD5736 Approved
0.6951 Remote Similarity NPD3226 Approved
0.6939 Remote Similarity NPD7457 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6535 Approved
0.6923 Remote Similarity NPD6534 Approved
0.6919 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6919 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6919 Remote Similarity NPD6166 Phase 2
0.6919 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6914 Remote Similarity NPD5401 Approved
0.6903 Remote Similarity NPD230 Phase 1
0.6903 Remote Similarity NPD6355 Discontinued
0.6901 Remote Similarity NPD6858 Approved
0.6901 Remote Similarity NPD7094 Approved
0.6898 Remote Similarity NPD7435 Discontinued
0.6897 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6892 Remote Similarity NPD6287 Discontinued
0.6886 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6879 Remote Similarity NPD4141 Clinical (unspecified phase)
0.6857 Remote Similarity NPD7074 Phase 3
0.6853 Remote Similarity NPD4869 Clinical (unspecified phase)
0.6845 Remote Similarity NPD3817 Phase 2
0.6842 Remote Similarity NPD7199 Phase 2
0.6842 Remote Similarity NPD6959 Discontinued
0.6839 Remote Similarity NPD3818 Discontinued
0.6835 Remote Similarity NPD2935 Discontinued
0.6829 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6826 Remote Similarity NPD1934 Approved
0.6815 Remote Similarity NPD7097 Phase 1
0.681 Remote Similarity NPD2533 Approved
0.681 Remote Similarity NPD2534 Approved
0.681 Remote Similarity NPD2532 Approved
0.681 Remote Similarity NPD8389 Clinical (unspecified phase)
0.681 Remote Similarity NPD7410 Clinical (unspecified phase)
0.68 Remote Similarity NPD7054 Approved
0.6792 Remote Similarity NPD2346 Discontinued
0.6788 Remote Similarity NPD8462 Phase 1
0.6786 Remote Similarity NPD1465 Phase 2
0.6784 Remote Similarity NPD5494 Approved
0.678 Remote Similarity NPD6764 Approved
0.678 Remote Similarity NPD6765 Approved
0.6774 Remote Similarity NPD7713 Phase 3
0.6772 Remote Similarity NPD3748 Approved
0.6771 Remote Similarity NPD7874 Approved
0.6771 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6765 Remote Similarity NPD1238 Approved
0.6761 Remote Similarity NPD7472 Approved
0.6755 Remote Similarity NPD6823 Phase 2
0.6753 Remote Similarity NPD7095 Approved
0.6748 Remote Similarity NPD6799 Approved
0.6742 Remote Similarity NPD7808 Phase 3
0.6739 Remote Similarity NPD1930 Approved
0.6739 Remote Similarity NPD6647 Phase 2
0.6739 Remote Similarity NPD1931 Clinical (unspecified phase)
0.6739 Remote Similarity NPD1929 Approved
0.6738 Remote Similarity NPD6780 Approved
0.6738 Remote Similarity NPD6777 Approved
0.6738 Remote Similarity NPD6778 Approved
0.6738 Remote Similarity NPD6779 Approved
0.6738 Remote Similarity NPD6776 Approved
0.6738 Remote Similarity NPD6781 Approved
0.6738 Remote Similarity NPD6782 Approved
0.6735 Remote Similarity NPD8404 Phase 2
0.6735 Remote Similarity NPD9545 Approved
0.673 Remote Similarity NPD2438 Suspended
0.672 Remote Similarity NPD7697 Approved
0.672 Remote Similarity NPD7698 Approved
0.672 Remote Similarity NPD7696 Phase 3
0.6719 Remote Similarity NPD8151 Discontinued
0.671 Remote Similarity NPD6798 Discontinued
0.6691 Remote Similarity NPD164 Approved
0.6691 Remote Similarity NPD5909 Discontinued
0.6691 Remote Similarity NPD1237 Approved
0.669 Remote Similarity NPD2067 Discontinued
0.6687 Remote Similarity NPD6002 Phase 3
0.6687 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6687 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6687 Remote Similarity NPD5763 Approved
0.6687 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6687 Remote Similarity NPD5762 Approved
0.6687 Remote Similarity NPD6005 Phase 3
0.6687 Remote Similarity NPD6004 Phase 3
0.6685 Remote Similarity NPD7251 Discontinued
0.6684 Remote Similarity NPD7871 Phase 2
0.6684 Remote Similarity NPD7870 Phase 2
0.6667 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8032 Phase 2
0.6667 Remote Similarity NPD4807 Approved
0.6667 Remote Similarity NPD7305 Phase 1
0.6667 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6667 Remote Similarity NPD3749 Approved
0.6667 Remote Similarity NPD4806 Approved
0.6667 Remote Similarity NPD6233 Phase 2
0.6667 Remote Similarity NPD7701 Phase 2
0.6667 Remote Similarity NPD7033 Discontinued
0.6667 Remote Similarity NPD4110 Phase 3
0.6667 Remote Similarity NPD4308 Phase 3
0.6667 Remote Similarity NPD2799 Discontinued
0.6649 Remote Similarity NPD7801 Approved
0.6648 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6648 Remote Similarity NPD3751 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data